To include your compound in the COVID-19 Resource Center, submit it here.

Actelion shareholders rebuff Elliott

Actelion Ltd. (SIX:ATLN) shareholders backed the current board's strategy by rejecting all proposals from activist shareholder Elliott Advisors at the biotech's

Read the full 210 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE